Physician profile
David L Conner
NPI 1093801631
$1,201.22
in general payments reported to CMS, 2019-2025
15 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $114 · 2021: $68.32 · 2023: $18.19 · 2024: $391 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $361.18 | 2020-2025 | Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $282.09 | 2019 | |
| Gilead Sciences, INC. | $140.05 | 2019-2024 | Epclusa |
| Pfizer INC. | $107.94 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $66.46 | 2019-2021 | |
| Novo Nordisk INC | $55.05 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $45.29 | 2019-2020 | |
| Amgen INC. | $20.47 | 2019 | |
| Indivior INC. | $20.41 | 2024 | Sublocade |
| Bayer Healthcare Pharmaceuticals INC. | $20.40 | 2021 | |
| Merck Sharp & Dohme LLC | $19.43 | 2019 | |
| Exact Sciences Corporation | $18.19 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $16.16 | 2020 | |
| Abbvie INC. | $15.53 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.